{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:14:19Z","timestamp":1773281659304,"version":"3.50.1"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa Do Estado de S\u00e3o Paulo"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> The treatment of most severe COVID-19 patients included the large-scale use of sedatives and analgesics\u2013possibly in higher doses than usual\u2013which was reported in the literature. The use of drugs that decrease mortality is necessary and opioids are important agents in procedures such as orotracheal intubation. However, these drugs seem to have been overestimated in the COVID-19 pandemic. We performed a review of the PubMed-Medline database to evaluate the use of opioids during this period. The following descriptors were used to enhance the search for papers: \u201cOpioids\u201d, \u201cCOVID-19,\u201d \u201cCOVID-19 pandemic,\u201d \u201cSARS-CoV-2,\u201d \u201cOpioid use disorder,\u201d \u201cOpioid dependence\u201d and the names of the drugs used. We also evaluated the distribution of COVID-19 patients in Brazil and the applicability of opioids in our country during the COVID-19 pandemic.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Several positive points were found in the use of opioids in the COVID-19 pandemic, for instance, they can be used for analgesia in orotracheal intubation, for chronic pain management, and as coadjutant in the management of acute intensification of pain. However, high doses of opioids might exacerbate the respiratory depression found in COVID-19 patients, their chronic use can trigger opioid tolerance and the higher doses used during the pandemic might result in greater adverse effects. Unfortunately, the pandemic also affected individuals with opioid use disorder, not only those individuals are at higher risk of mortality, hospitalization and need for ventilatory support, but measures taken to decrease the SARS-CoV-2 spread such as social isolation, might negatively affect the treatment for opioid use disorder. In Brazil, only morphine, remifentanil and fentanyl are available in the basic health care system for the treatment of COVID-19 patients. Out of the 5,273,598 opioid units used in this period all over the country, morphine, fentanyl, and remifentanil, accounted for, respectively, 559,270 (10.6%), 4,624,328 (87.6%), and 90,000 (1.8%) units. Many Brazilian regions with high number of confirmed cases of COVID-19 had few units of opioids available, as the Southeast region, with a 0.23 units of opioids per confirmed COVID-19 case, and the South region, with 0.05 units. In the COVID-19 pandemic scenario, positive points related to opioids were mainly the occurrence of analgesia, to facilitate intubation and their use as coadjutants in the management of acute intensification of pain, whereas the negative points were indiscriminate use, the presence of human immunosuppressor response and increased adverse effects due to higher doses of the drug.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The importance of rational and individualized use of analgesic hypnotics and sedative anesthetics should be considered at all times, especially in situations of high demand such as the COVID-19 pandemic.<\/jats:p>","DOI":"10.3389\/fphar.2021.758637","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T06:57:50Z","timestamp":1641452270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Opioids in COVID-19: Two Sides of a Coin"],"prefix":"10.3389","volume":"12","author":[{"given":"Camila Vantini Capasso","family":"Palamim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Negri","family":"Boschiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al\u00e9thea Guimar\u00e3es","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Eduardo","family":"Valencise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Augusto Lima","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/phar.2471","article-title":"Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID-19","volume":"40","author":"Adams","year":"2020","journal-title":"Pharmacotherapy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7326\/M20-1141","article-title":"An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19","volume":"173","author":"Alexander","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"B3","unstructured":"\u201cTracheal Intubation Medications,\u201d in StatPearls (Treasure Island (FL): StatPearls Publishing)\n            AllenP.\n            DesaiN. M.\n            LawrenceV. N.\n          2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/0885066620951426","article-title":"Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages","volume":"36","author":"Ammar","year":"2021","journal-title":"J. Intensive Care Med."},{"key":"B5","unstructured":"Anahp Presents to Anvisa Research that Indicates Low Stocks of Drugs to Treat Covid-192021"},{"key":"B6","unstructured":"Analgesia and Sedation in COVID-192021"},{"key":"B7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13011-020-00333-y","article-title":"A Double-Edged Sword of Using Opioids and COVID-19: a Toxicological View","volume":"15","author":"Ataei","year":"2020","journal-title":"Subst. Abuse Treat. Prev. Pol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1176\/appi.ps.202000534","article-title":"The Impact of Substance Use Disorder on COVID-19 Outcomes","volume":"72","author":"Baillargeon","year":"2021","journal-title":"PS"},{"key":"B9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1590\/S1516-44462004000400011","article-title":"Brazilian Guideline for the Treatment of Patients with Opioids Dependence Syndrome","volume":"26","author":"Baltieri","year":"2004","journal-title":"Braz. J. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 - Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.2174\/138161212803582469","article-title":"Non-analgesic Effects of Opioids: Opioid-Induced Respiratory Depression","volume":"18","author":"Boom","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5334\/aogh.3182","article-title":"One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview","volume":"87","author":"Boschiero","year":"2021","journal-title":"Ann. Glob. Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainresrev.2009.09.008","article-title":"Kappa-Opioid Receptor Signaling and Brain Reward Function","volume":"62","author":"Bruijnzeel","year":"2009","journal-title":"Brain Res. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1378\/chest.10-0534","article-title":"Mechanisms of Dyspnea","volume":"138","author":"Burki","year":"2010","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"108543","DOI":"10.1016\/j.jsat.2021.108543","article-title":"The COVID-19 Pandemic and Opioid Use Disorder: Expanding Treatment with Buprenorphine, and Combining Safety Precautions with Telehealth","author":"Cales","year":"2021","journal-title":"J. Substance Abuse Treat."},{"key":"B16","unstructured":"CDC WONDER2021"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0246318","DOI":"10.1371\/journal.pone.0246318","article-title":"COVID-19 ICU and Mechanical Ventilation Patient Characteristics and Outcomes-A Systematic Review and Meta-Analysis","volume":"16","author":"Chang","year":"2021","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4097\/kja.21106","article-title":"Neuromuscular Blockade Management in Patients with COVID-19","volume":"74","author":"Chaves-Cardona","year":"2021","journal-title":"Korean J. Anesthesiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The Therapeutic Potential of \u03ba-opioids for Treatment of Pain and Addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1476-5381.1993.tb13898.x","article-title":"Electrophysiological Actions of Alfentanil: Intracellular Studies in the Rat Locus Coeruleus Neurones","volume":"110","author":"Chiu","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/jcmm.15927","article-title":"Multiple Potential Targets of Opioids in the Treatment of Acute Respiratory Distress Syndrome from COVID-19","volume":"25","author":"Cismaru","year":"2021","journal-title":"J. Cel Mol Med"},{"key":"B22","unstructured":"Ag\u00eancia Brasil2021"},{"key":"B23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1017\/ipm.2020.47","article-title":"Addiction Psychiatry and COVID-19: Impact on Patients and Service Provision","volume":"37","author":"Columb","year":"2020","journal-title":"Ir J. Psychol. Med."},{"key":"B24","unstructured":"Coronav\u00edrus Brasil2021"},{"key":"B25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.drugpo.2019.07.006","article-title":"Legal and Policy Changes Urgently Needed to Increase Access to Opioid Agonist Therapy in the United States","volume":"73","author":"Davis","year":"2019","journal-title":"Int. J. Drug Pol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/10826084.2018.1517175","article-title":"A Recent History of Opioid Use in the US: Three Decades of Change","volume":"54","author":"Dayer","year":"2019","journal-title":"Subst. Use Misuse"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global Patterns of Opioid Use and Dependence: Harms to Populations, Interventions, and Future Action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation\/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit. Care Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E465","DOI":"10.3390\/brainsci10070465","article-title":"COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives","volume":"10","author":"Dro\u017cd\u017cal","year":"2020","journal-title":"Brain Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/00000542-199311000-00004","article-title":"The Pharmacokinetics of the New Short-Acting Opioid Remifentanil (GI87084B) in Healthy Adult Male Volunteers","volume":"79","author":"Egan","year":"1993","journal-title":"Anesthesiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijdrr.2017.05.001","article-title":"Disaster Preparedness Among Opioid Treatment Programs: Policy Recommendations from State Opioid Treatment Authorities","volume":"23","author":"Elliott","year":"2017","journal-title":"Int. J. Disaster Risk Reduction"},{"key":"B32","unstructured":"Palladone Capsules 1.3 Mg - Summary of Product Characteristics (SmPC) - (Emc)2021"},{"key":"B33","unstructured":"Trendspotter Briefing: Impact of COVID-19 on Patterns of Drug Use and Drug-Related Harms in Europe2021"},{"key":"B34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1590\/S0103-84781999000400019","article-title":"Utiliza\u00e7\u00e3o de alfentanil, sufentanil e fentanil em c\u00e3es anestesiados com halotano","volume":"29","author":"Fantoni","year":"1999","journal-title":"Cienc. Rural"},{"key":"B35","unstructured":"Federation of Santa Casas and Other Charitable Hospitals of S\u00e3o Paulo2021"},{"key":"B36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamapsychiatry.2018.3685","article-title":"Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver","volume":"76","author":"Fiscella","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"B37","unstructured":"Quatro medicamentos de 'kit intuba\u00e7\u00e3o' est\u00e3o em falta no Rio2021"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3389\/fimmu.2019.02914","article-title":"Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review from Animal and Human Studies","volume":"10","author":"Franchi","year":"2019","journal-title":"Front. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pmr.2020.01.007","article-title":"Opioids: Pharmacology, Physiology, and Clinical Implications in Pain Medicine","volume":"31","author":"Friedman","year":"2020","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0255396","DOI":"10.1371\/journal.pone.0255396","article-title":"Experiences of People with Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Study","volume":"16","author":"Galarneau","year":"2021","journal-title":"PLoS One"},{"key":"B41","unstructured":"I Levantamento Domiciliar sobre o Uso de Drogas Psicotr\u00f3picas no Brasil: estudo envolvendo as 107 maiores cidades Do pa\u00eds\n            Galdur\u00f3zJ. C. F. N.\n            CebridU. F.\n          2003"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/ijerph18041967","article-title":"Changes in Drug Use Patterns during the COVID-19 Pandemic in Italy: Monitoring a Vulnerable Group by Hair Analysis","volume":"18","author":"Gili","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S2468-2667(19)30060-X","article-title":"The Effect of Entry and Retention in Opioid Agonist Treatment on Contact with the Criminal justice System Among Opioid-dependent People: a Retrospective Cohort Study","volume":"4","author":"Gisev","year":"2019","journal-title":"Lancet Public Health"},{"key":"B44","first-page":"65","article-title":"Opi\u00f3ides e Antagonistas","author":"Gozzani","year":"1994","journal-title":"Rev. Bras. Anestesiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/08897077.2020.1752351","article-title":"Opioid Use Disorder and the COVID 19 Pandemic: A Call to Sustain Regulatory Easements and Further Expand Access to Treatment","volume":"41","author":"Green","year":"2020","journal-title":"Subst. Abus"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1124\/jpet.115.226977","article-title":"Modeling Respiratory Depression Induced by Remifentanil and Propofol during Sedation and Analgesia Using a Continuous Noninvasive Measurement of pCO2","volume":"356","author":"Hannam","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s13054-020-03200-1","article-title":"Delirium and Encephalopathy in Severe COVID-19: a Cohort Analysis of ICU Patients","volume":"24","author":"Helms","year":"2020","journal-title":"Crit. Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1186\/s12889-021-11495-0","article-title":"Opioid Use Disorder Treatment Disruptions during the Early COVID-19 Pandemic and Other Emergent Disasters: a Scoping Review Addressing Dual Public Health Emergencies","volume":"21","author":"Henderson","year":"2021","journal-title":"BMC Public Health"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/brain\/awm255","article-title":"Imaging of Opioid Receptors in the central Nervous System","volume":"131","author":"Henriksen","year":"2008","journal-title":"Brain"},{"key":"B51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/ALN.0000000000000937","article-title":"Patient-controlled Analgesia with Target-Controlled Infusion of Hydromorphone in Postoperative Pain Therapy","volume":"124","author":"Jeleazcov","year":"2016","journal-title":"Anesthesiology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/s0952-8180(02)00404-x","article-title":"A Comparison of the Remifentanil and Fentanyl Adverse Effect Profile in a Multicenter Phase IV Study","volume":"14","author":"Joshi","year":"2002","journal-title":"J. Clin. Anesth."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e2118223","DOI":"10.1001\/jamanetworkopen.2021.18223","article-title":"Methadone Access for Opioid Use Disorder during the COVID-19 Pandemic within the United States and Canada","volume":"4","author":"Joudrey","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1213\/ANE.0000000000005131","article-title":"The Use of Analgesia and Sedation in Mechanically Ventilated Patients with COVID-19 Acute Respiratory Distress Syndrome","volume":"131","author":"Kapp","year":"2020","journal-title":"Anesth. Analg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/ADM.0000000000000684","article-title":"Opioid Use Disorder and COVID-19: Crashing of the Crises","volume":"14","author":"Khatri","year":"2020","journal-title":"J. Addict. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The Neurobiology of Opioid Dependence: Implications for Treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13054-020-02882-x10.5114\/ait.2020.95164","article-title":"COVID-19: What Do We Need to Know about ICU Delirium during the SARS-CoV-2 Pandemic?","volume":"52","author":"Kotfis","year":"2020","journal-title":"Anaesthesiol Intensive Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/17441692.2019.1629610","article-title":"Non-medical Use of Opioid Analgesics in Contemporary Brazil: Findings from the 2015 Brazilian National Household Survey on Substance Use","volume":"15","author":"Krawczyk","year":"2020","journal-title":"Glob. Public Health"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/0006-2952(93)90462-6","article-title":"Effects of Morphine and its Metabolites on Opiate Receptor Binding, cAMP Formation and [3H]noradrenaline Release from SH-Sy5y Cells","volume":"46","author":"Lambert","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/104990910302000113","article-title":"Opioids, Respiratory Function, and Dyspnea","volume":"20","author":"LeGrand","year":"2003","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"B62","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1365-2044.1999.00946.x","article-title":"Time Course of Changes in Breathing Pattern in Morphine- and Oxycodone-Induced Respiratory Depression","volume":"54","author":"Leino","year":"1999","journal-title":"Anaesthesia"},{"key":"B63","doi-asserted-by":"publisher","first-page":"20015","DOI":"10.1039\/C7RA01346A","article-title":"Synthesis and Biological Evaluation of Fentanyl Acrylic Derivatives","volume":"7","author":"Li","year":"2017","journal-title":"RSC Adv."},{"key":"B64","unstructured":"Localiza SUS2021"},{"key":"B65","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpainsymman.2005.01.012","article-title":"Pharmacokinetic-pharmacodynamic Modeling of Opioids","volume":"29","author":"L\u00f6tsch","year":"2005","journal-title":"J. Pain Symptom Manage."},{"key":"B66","first-page":"62","article-title":"Leaving Methadone Treatment: Lessons Learned, Lessons Forgotten, Lessons Ignored","volume":"68","author":"Magura","year":"2001","journal-title":"Mt Sinai J. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/00000542-197505000-00021","article-title":"Relative Analgesic Potencies of Morphine and Hydromorphone in Postoperative Pain","volume":"42","author":"Mahler","year":"1975","journal-title":"Anesthesiology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/dta.2982","article-title":"Increase in Drugs-Of-Abuse Findings in post-mortem Toxicology Due to COVID-19 Restrictions-First Observations in Finland","volume":"13","author":"Mariottini","year":"2021","journal-title":"Drug Test. Anal."},{"key":"B69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0028-3908(91)90056-h","article-title":"Fentanyl and Sufentanil Inhibit Agonist Binding to 5-HT1A Receptors in Membranes from the Rat Brain","volume":"30","author":"Martin","year":"1991","journal-title":"Neuropharmacology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/08897077.2021.1890676","article-title":"COVID-19: A Catalyst for Change in Telehealth Service Delivery for Opioid Use Disorder Management","volume":"42","author":"Mehtani","year":"2021","journal-title":"Subst. Abus"},{"key":"B71","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bjane.2018.12.00710.1016\/j.bjan.2018.11.008","article-title":"Trends in Hospital Consumption of Analgesics after the Implementation of a Pain Performance Improvement Plan","volume":"69","author":"Monje","year":"2019","journal-title":"Rev. Bras. Anestesiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1523\/JNEUROSCI.4611-10.2011","article-title":"PreBotzinger Complex Neurokinin-1 Receptor-Expressing Neurons Mediate Opioid-Induced Respiratory Depression","volume":"31","author":"Montandon","year":"2011","journal-title":"J. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"113142","DOI":"10.1016\/j.psychres.2020.113142","article-title":"Avoiding a New Epidemic during a Pandemic: The Importance of Assessing the Risk of Substance Use Disorders in the COVID-19 Era","volume":"290","author":"Mota","year":"2020","journal-title":"Psychiatry Res."},{"key":"B74","unstructured":"MS-SUS COVID-19 Medications2021"},{"key":"B75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.imlet.2013.04.003","article-title":"The Plasma Levels of the Cytokines in Opium-Addicts and the Effects of Opium on the Cytokines Secretion by Their Lymphocytes","volume":"152","author":"Nabati","year":"2013","journal-title":"Immunol. Lett."},{"key":"B76","volume-title":"Opportunities to Improve Opioid Use Disorder and Infectious Disease Services: Integrating Responses to a Dual Epidemic","year":"2020"},{"key":"B77","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1089\/pop.2020.0230","article-title":"The Opioid Epidemic within the COVID-19 Pandemic: Drug Testing in 2020","volume":"24","author":"Niles","year":"2021","journal-title":"Popul. Health Manag."},{"key":"B78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1345\/aph.1Q446","article-title":"Sedation and Analgesia Usage in Severe Pandemic H1N1 (2009) Infection: a Comparison to Respiratory Failure Secondary to Other Infectious Pneumonias","volume":"46","author":"Olafson","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"B79","unstructured":"CDC\u2019s Response to the Opioid Overdose Epidemic2021"},{"key":"B80","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S2213-2600(20)30570-1","article-title":"Sedation in Mechanically Ventilated Patients with COVID-19","volume":"9","author":"Page","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"114","DOI":"10.20452\/pamw.2136","article-title":"Management of Pain, Agitation, and Delirium in Critically Ill Patients","volume":"124","author":"Pandharipande","year":"2014","journal-title":"Pol. Arch. Med. Wewn"},{"key":"B82","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the Control of Respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"B83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S2213-2600(20)30552-X","article-title":"Prevalence and Risk Factors for Delirium in Critically Ill Patients with COVID-19 (COVID-D): a Multicentre Cohort Study","volume":"9","author":"Pun","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-020-03006-1","article-title":"Mortality Rates of Patients with COVID-19 in the Intensive Care Unit: a Systematic Review of the Emerging Literature","volume":"24","author":"Quah","year":"2020","journal-title":"Crit. Care"},{"key":"B85","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S2213-2600(20)30560-9","article-title":"Characterisation of the First 250,000 Hospital Admissions for COVID-19 in Brazil: a Retrospective Analysis of Nationwide Data","volume":"9","author":"Ranzani","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"B86","volume-title":"Essential Medication National List","year":"2020"},{"key":"B87","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jama.2009.56","article-title":"Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients: a Randomized Trial","volume":"301","author":"Riker","year":"2009","journal-title":"JAMA"},{"key":"B88","doi-asserted-by":"publisher","first-page":"678","DOI":"10.7326\/L17-0612","article-title":"Opioids and Chest Wall Rigidity during Mechanical Ventilation","volume":"168","author":"Roan","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMp1803982","article-title":"Methadone in Primary Care - One Small Step for Congress, One Giant Leap for Addiction Treatment","volume":"379","author":"Samet","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/brain\/awq327","article-title":"Neuroanatomical Characteristics of the Human Pre-b\u00f6tzinger Complex and its Involvement in Neurodegenerative Brainstem Diseases","volume":"134","author":"Schwarzacher","year":"2011","journal-title":"Brain"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/ejp.1728","article-title":"Is Europe Facing an Opioid Epidemic: What Does European Monitoring Data Tell Us?","volume":"25","author":"Seyler","year":"2021","journal-title":"Eur. J. Pain"},{"key":"B93","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality Risk during and after Opioid Substitution Treatment: Systematic Review and Meta-Analysis of Cohort Studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"B94","unstructured":"Prevalence of Drug Use2021"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coph.2008.12.009","article-title":"Peripheral Mechanisms of Opioid Analgesia","volume":"9","author":"Stein","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"12939","DOI":"10.7196\/SAMJ.2020.v110i6.14832","article-title":"COVID-19 Restrictions and Increased Risk of Overdose for Street-Based People with Opioid Dependence in South Africa","volume":"110","author":"Stowe","year":"2020","journal-title":"S Afr. Med. J."},{"key":"B97","article-title":"Mainstreaming Addiction Treatment Act of 2019","author":"Summary of","year":"2482","journal-title":"GovTrack.us"},{"key":"B98","unstructured":"Conselho Regional De Medicina2021"},{"key":"B99","doi-asserted-by":"publisher","first-page":"107714","DOI":"10.1016\/j.drugalcdep.2019.107714","article-title":"Incidence and Predictors of Drug Overdoses Among a Cohort of >10,000 Patients Treated for Substance Use Disorder","volume":"206","author":"Thylstrup","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2021.09.002","article-title":"Opioid Use and Misuse in Europe: COVID-19 New Challenges?","author":"Torrens","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B101","unstructured":"CDC\u2019s Response to the Opioid Overdose Epidemic2021"},{"key":"B102","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tmi.13383","article-title":"The COVID-19 Epidemic","volume":"25","author":"Velavan","year":"2020","journal-title":"Trop. Med. Int. Health"},{"key":"B103","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4088\/pcc.v07n0301","article-title":"Opioids and Methadone Equivalents for Clinicians","volume":"7","author":"Vieweg","year":"2005","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"B104","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0028-3908(83)90162-4","article-title":"Characteristics of [3H]fentanyl Binding to the Opiate Receptor","volume":"22","author":"Villiger","year":"1983","journal-title":"Neuropharmacology"},{"key":"B105","unstructured":"Provisional Drug Overdose Data2021"},{"key":"B106","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/wps.20633","article-title":"Addressing the Opioid Crisis Globally","volume":"18","author":"Volkow","year":"2019","journal-title":"World Psychiatry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 Risk and Outcomes in Patients with Substance Use Disorders: Analyses from Electronic Health Records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B108","unstructured":"COVID-19) Dashboard2021"},{"key":"B109","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5847\/wjem.j.1920-8642.2015.02.011","article-title":"Effect of Sedation on Short-Term and Long-Term Outcomes of Critically Ill Patients with Acute Respiratory Insufficiency","volume":"6","author":"Xing","year":"2015","journal-title":"World J. Emerg. Med."},{"key":"B111","first-page":"350","article-title":"Efficacy and Tolerance of Narcotic Analgesics at the Mu Opioid Receptor in Differentiated Human Neuroblastoma Cells","volume":"245","author":"Yu","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B112","doi-asserted-by":"publisher","first-page":"110195","DOI":"10.1016\/j.biopha.2020.110195","article-title":"New Understanding of the Damage of SARS-CoV-2 Infection outside the Respiratory System","volume":"127","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.758637\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T06:58:05Z","timestamp":1641452285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.758637\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":112,"alternative-id":["10.3389\/fphar.2021.758637"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.758637","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"article-number":"758637"}}